calendar
33,067 catalysts · 13,398 approval · 5,000 device 510k · 4,728 grant · 3,150 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
33,067 catalysts · 13,398 approval · 5,000 device 510k · 4,728 grant · 3,150 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: BAUSCH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: BAUSCH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: UNIQUE. Form: TABLET. Route: ORAL
Sponsor: TORRENT. Form: CAPSULE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: HISAMITSU PHARM CO. Form: PATCH. Route: TOPICAL
Sponsor: ZYLA. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL-28
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL